explore -WSS

explore

author：entertainment 2025-10-02 12:31:43 - browse：87755

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Study suggests Covid rebound is far more common with Paxlovid than without

WSS

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Readout Newsletter: Zepbound, Valneva's vaccine, and more

What we know about the American soldier detained in North Korea

NIH chief: government has fallen behind pharma on clinical trials

Type 2 diabetes prevention programs work at large scale: study

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

focus

explore

hotspot

What does generative AI mean for health care? We asked experts

15 die by electrocution after transformer explodes in northern India

Alkermes shareholders re

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Drug repurposing or repositioning? The language matters

Experimental asthma app from Apple and Anthem shows promise

Continuity nursing helped my family in our darkest PICU moments

A letter from the executive editor: STAT UnitedHealth investigation

The cancer drug shortage isn’t new — and neither are the solutions

First transplant of an entire human eye performed

focus

Medical school prerequisites are outdated

Publishing genetic code of viruses could cause disaster

Carbon Health diabetes program, a test of data

US soldier in North Korean custody after crossing DMZ line

NIH chief: government has fallen behind pharma on clinical trials

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

explore

knowledge

hotspot

focus